Endpoints News Mar 23, 2026 Novartis to invest $480M in China following AstraZeneca and Lilly pledges
FierceBiotech Mar 23, 2026 Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
FierceBiotech Mar 20, 2026 Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
Endpoints News Mar 20, 2026 Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Endpoints News Feb 26, 2026 Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
FierceBiotech Feb 18, 2026 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Endpoints News Feb 18, 2026 Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News Feb 18, 2026 Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results